Pusapati RV - Search Results

1

ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.

Pusapati RV, Rounbehler RJ, Hong S, Powers JT, Yan M, Kiguchi K, McArthur MJ, Wong PK, Johnson DG. Pusapati RV, et al. Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1446-51. doi: 10.1073/pnas.0507367103. Epub 2006 Jan 23. Proc Natl Acad Sci U S A. 2006. PMID: 16432227 Free PMC article.

2

Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis.

Paulson QX, Pusapati RV, Hong S, Weaks RL, Conti CJ, Johnson DG. Paulson QX, et al. Among authors: pusapati rv. Oncogene. 2008 Aug 21;27(36):4954-61. doi: 10.1038/onc.2008.138. Epub 2008 May 12. Oncogene. 2008. PMID: 18469863

3

Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.

Hong S, Pusapati RV, Powers JT, Johnson DG. Hong S, et al. Among authors: pusapati rv. Cell Cycle. 2006 Apr;5(8):801-3. doi: 10.4161/cc.5.8.2638. Epub 2006 Apr 17. Cell Cycle. 2006. PMID: 16582589

4

E2F2 suppresses Myc-induced proliferation and tumorigenesis.

Pusapati RV, Weaks RL, Rounbehler RJ, McArthur MJ, Johnson DG. Pusapati RV, et al. Mol Carcinog. 2010 Feb;49(2):152-6. doi: 10.1002/mc.20584. Mol Carcinog. 2010. PMID: 19798698 Free PMC article.

5

TORquing metabolic reprogramming in cancer cells.

Pusapati R, Settleman J. Pusapati R, et al. Cell Cycle. 2016 Sep 16;15(18):2387-8. doi: 10.1080/15384101.2016.1204850. Epub 2016 Jun 30. Cell Cycle. 2016. PMID: 27362787 Free PMC article. No abstract available.

6

mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.

Pusapati RV, Daemen A, Wilson C, Sandoval W, Gao M, Haley B, Baudy AR, Hatzivassiliou G, Evangelista M, Settleman J. Pusapati RV, et al. Cancer Cell. 2016 Apr 11;29(4):548-562. doi: 10.1016/j.ccell.2016.02.018. Epub 2016 Mar 24. Cancer Cell. 2016. PMID: 27052953 Free article.

7

Acquired resistance of non-small cell lung cancer cells to MET kinase inhibition is mediated by a switch to epidermal growth factor receptor dependency.

McDermott U, Pusapati RV, Christensen JG, Gray NS, Settleman J. McDermott U, et al. Among authors: pusapati rv. Cancer Res. 2010 Feb 15;70(4):1625-34. doi: 10.1158/0008-5472.CAN-09-3620. Epub 2010 Feb 2. Cancer Res. 2010. PMID: 20124471 Free PMC article.

8

Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition.

Boudreau A, Purkey HE, Hitz A, Robarge K, Peterson D, Labadie S, Kwong M, Hong R, Gao M, Del Nagro C, Pusapati R, Ma S, Salphati L, Pang J, Zhou A, Lai T, Li Y, Chen Z, Wei B, Yen I, Sideris S, McCleland M, Firestein R, Corson L, Vanderbilt A, Williams S, Daemen A, Belvin M, Eigenbrot C, Jackson PK, Malek S, Hatzivassiliou G, Sampath D, Evangelista M, O'Brien T. Boudreau A, et al. Nat Chem Biol. 2016 Oct;12(10):779-86. doi: 10.1038/nchembio.2143. Epub 2016 Aug 1. Nat Chem Biol. 2016. PMID: 27479743

9

Hepatitis B vaccination in premature and low birth weight (LBW) babies.

Bhave S, Bhise S, Chavan SC, Naik SS, Pusapati RV, Bavdekar A, Pandit A. Bhave S, et al. Among authors: pusapati rv. Indian Pediatr. 2002 Jul;39(7):625-31. Indian Pediatr. 2002. PMID: 12147887 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters